Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication - PubMed (original) (raw)
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
B A Sullenger et al. Cell. 1990.
Abstract
Overexpression of TAR-containing sequences (TAR decoys) was used to render cells resistant to HIV replication. A chimeric tRNA(meti)-TAR transcription unit contained in a double copy murine retroviral vector was used to express high levels of HIV-1 TAR-containing transcripts in CEM SS cells. Replication of HIV-1 was inhibited over 99% in cells expressing chimeric tRNA-TAR transcripts, but an amphotropic murine retrovirus replicated normally in these cells. Expression of TAR sequences in CEM SS cells had no adverse effects on cell viability, indicating that essential cellular factors are not being sequestered in these cells. TAR decoy RNA-mediated HIV inhibition may also be effective against natural HIV isolates in spite of their hypervariable nature, as suggested by the fact that replication of SIVmac was also inhibited in cells expressing HIV-1 TAR decoys.
Similar articles
- Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.
Lee TC, Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Lee TC, et al. New Biol. 1992 Jan;4(1):66-74. New Biol. 1992. PMID: 1536832 - Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Sullenger BA, et al. J Virol. 1991 Dec;65(12):6811-6. doi: 10.1128/JVI.65.12.6811-6816.1991. J Virol. 1991. PMID: 1942253 Free PMC article. - Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW, Gallardo HF, Gaspar O, Smith C, Gilboa E. Lee SW, et al. Gene Ther. 1995 Aug;2(6):377-84. Gene Ther. 1995. PMID: 7584112 - Exosomal packaging of trans-activation response element (TAR) RNA by HIV-1 infected cells: a pro-malignancy message delivery to cancer cells.
Sharma NK. Sharma NK. Mol Biol Rep. 2019 Jun;46(3):3607-3612. doi: 10.1007/s11033-019-04770-2. Epub 2019 Mar 22. Mol Biol Rep. 2019. PMID: 30903574 Review. - TAR decoys and trans-dominant gag mutant for HIV-1 gene therapy.
Lisziewicz J. Lisziewicz J. Antibiot Chemother (1971). 1996;48:192-7. doi: 10.1159/000425177. Antibiot Chemother (1971). 1996. PMID: 8726525 Review. No abstract available.
Cited by
- Aptamers and their biological applications.
Song KM, Lee S, Ban C. Song KM, et al. Sensors (Basel). 2012;12(1):612-31. doi: 10.3390/s120100612. Epub 2012 Jan 9. Sensors (Basel). 2012. PMID: 22368488 Free PMC article. Review. - Nuclear Factor-κB Decoy Oligodeoxynucleotide Attenuates Cartilage Resorption In Vitro.
Nemoto H, Sakai D, Watson D, Masuda K. Nemoto H, et al. Bioengineering (Basel). 2024 Jan 1;11(1):46. doi: 10.3390/bioengineering11010046. Bioengineering (Basel). 2024. PMID: 38247922 Free PMC article. - Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.
Shimada T, Fujii H, Mitsuya H, Nienhuis AW. Shimada T, et al. J Clin Invest. 1991 Sep;88(3):1043-7. doi: 10.1172/JCI115365. J Clin Invest. 1991. PMID: 1885765 Free PMC article. - Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments.
Holzmayer TA, Pestov DG, Roninson IB. Holzmayer TA, et al. Nucleic Acids Res. 1992 Feb 25;20(4):711-7. doi: 10.1093/nar/20.4.711. Nucleic Acids Res. 1992. PMID: 1531871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources